# Pharmacology of Mupirocin in Nasal Application in Healthy Volunteers: Monocentric Study

> **NCT06368856** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Centre Hospitalier Universitaire de Saint Etienne** · enrollment: 40 (actual)

## Conditions studied

- Healthy
- Staphylococcus Aureus Infection

## Interventions

- **DRUG:** Mupirocin (50 mg)
- **DRUG:** Mupirocin (500 mg)
- **BIOLOGICAL:** blood samples after Single dose part
- **DIAGNOSTIC_TEST:** nasal swab after Single dose part
- **OTHER:** Collection of urine after Single dose part
- **DIAGNOSTIC_TEST:** nasal swab during Repeated dose part
- **OTHER:** Collection of urine during Repeated dose part
- **OTHER:** nasal swab after Repeated dose part

## Key facts

- **NCT ID:** NCT06368856
- **Lead sponsor:** Centre Hospitalier Universitaire de Saint Etienne
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-02-29
- **Primary completion:** 2025-03-04
- **Final completion:** 2025-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06368856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06368856, "Pharmacology of Mupirocin in Nasal Application in Healthy Volunteers: Monocentric Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06368856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*